| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Dube Eric M serves as a Chief Executive Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 56 sells. Those positions are worth an estimated $3.9M at current prices.
Historically, Dube Eric M's trades have earned a middling insider score of 56/100 across 23 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -17.8%.
The biggest single holding is TVTX (~$3.9M) as Chief Executive Officer. The recent filings there lean toward selling, a net 1,393,081 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 11,375 | $24.04 | $273,455.00 | -2.6% | -9.3% | +27.2% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 50,691 | $20.21 | $1,024,343.45 | -10.5% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 10,736 | $19.46 | $208,922.56 | -3.0% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 21,125 | $11.52 | $243,360.00 | -5.5% | +46.0% | +68.3% | |
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 19,122 | $8.70 | $166,435.06 | -5.2% | -30.2% | +137.9% | |
| Jan 23, 2024 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 7,873 | $8.96 | $70,542.08 | -3.2% | -37.0% | +109.5% | |
| Sep 5, 2023 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 4,455 | $14.71 | $65,533.05 | -1.8% | -55.7% | -29.2% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 8,196 | $22.25 | $182,361.00 | -3.3% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 6,442 | $21.50 | $138,503.00 | -4.2% | -2.9% | -58.3% | |
| Jan 5, 2023 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 5,625 | $20.75 | $116,718.75 | -3.5% | +1.6% | -57.9% |